ANTHONY PIAZZA: Open Payments
NPI 1164855003 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,235 in 31 payments from 11 companies in 2025. Trend: 2023 $550 · 2024 $754 · 2025 $2,235
Food & beverage: $2,235
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 2 | $1,485 |
| PFIZER INC. | 6 | $156 |
| CSL Behring | 4 | $128 |
| Aimmune Therapeutics, Inc. | 4 | $100 |
| ABBVIE INC. | 3 | $93 |
| Ferring Pharmaceuticals Inc. | 3 | $79 |
| Alexion Pharmaceuticals, Inc. | 3 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Shionogi Inc | 1 | $19 |
Products named: Rapiblyk, VYNDAQEL, Kcentra, VOWST, DALVANCE, REBYOTA, ULTOMIRIS, XIFAXAN.
Industry payments across TX — which companies pay providers there.
